Home News About us Comitato scientifico Iscriviti Utenti Etica Contenuti Guida Faq Stage Contatti ☰
Logo Pharmamedix
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sibutramina

Bibliografia - Quali fonti bibliografiche per Sibutramina?

  1. Appolinario J.C. et al., J. Clin. Psychiatry, 2002, 63 (1), 28.

  2. Aronne L.J. et al., Obesity (Silver Spring), 2010, consultabile on line http://www.ncbi.nlm.nih.gov/pubmed/20094043

  3. Bae S.K. et al., Drug Metab. Dispos., 2008, 36 (8), 1679.

  4. Bailey D.G., Dresser G.K., Am. J. Cardiovasc. Drugs, 2004, 4 (5), 281.

  5. Bray G.A. et al., Obes. Res., 1999, 7 (2), 189.

  6. Canadian Adverse Reaction Newsletter, 2003, 13 (3), 3.

  7. Chung J.Y. et al., J. Clin. Pharmacol., 2010, consultabile on line http://www.ncbi.nlm.nih.gov/pubmed/20350955

  8. Cole J.O. et al., J. Clin. Psychopharmacol., 1998, 18 (3), 231.

  9. Coletta D.K. et al., Diab. Vasc. Dis. Res., 2006, 3 (3), 186.

  10. Dahlin A., Beermann B., Eur. J. Clin. Pharmacol., 2007, 63 (2), 205.

  11. Daniels S.R. et al., Pediatrics, 2007, 120 (1), e147.

  12. Derosa G. et al., Metabolism, 2010, consultabile on line http://www.ncbi.nlm.nih.gov/pubmed/20423740

  13. De Santis M. et al., Drug Saf., 2006, 29, 255.

  14. Einarson A. et al., Eur. J. Obstet. Gynecol. Reprod. Biol., 2004, 116, 112.

  15. EMEA, 2010, “Questions and answers on the suspension of medicines containing sibutramine” consultabile on line http://www.ema.europa.eu/pdfs/human/referral/sibutramine/Sibutramine_Q&A_80817909en.pdf

  16. Ernest D. et al., Ann. Pharmacother., 2008, 42 (10), 1514.

  17. Esposito P. et al., Am. J. Kidney Dis., 2008, 52 (1), 137.

  18. Faria A.N. et al., Arq. Bras. Cardiol., 2002, 78 (2), 172.

  19. FDA, 2010, “Follow-Up to the November 2009 Early Communication about an Ongoing Safety Review of Sibutramine, Marketed as Meridia” consultabile on line http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm198206.htm

  20. Fu P.K. et al., Neurologist, 2010, 16 (2), 129.

  21. Gazdag G., Szabó Z., Neuropsychopharmacol. Hung., 2008, 10 (2), 107.

  22. Gokcel A. et al., J. Endocrinol. Invest., 2002, 25 (2), 101.

  23. Gokcel A. et al., Diabetes Obes. Metab., 2002a, 4 (1), 49.

  24. Halpern A. et al., Rev. Hosp. Clin. Fac. Med. Sao Paulo, 2002, 57 (3), 98.

  25. Hanotin C. et al., Obes. Res., 1998, 6 (4), 285.

  26. Hansen D.L. et al., Int. J. Obes. Metab. Disord., 1999, 23 (10), 1016.

  27. Hansen D.L. et al., Am. J. Clin. Nutr., 1998, 68 (8), 1180.

  28. Hansen H.H. et al., Eur. J. Pharmacol., 2010, consultabile on line http://www.ncbi.nlm.nih.gov/pubmed/20385125

  29. Harrison-Woolrych M. et al., Br. J. Clin. Pharmacol., 2006, 61 (4), 464.

  30. Heal D.J. et al., Int. J. Obes. Metab. Disord., 1998, 22 Suppl. 1, S18.

  31. James W.P. et al., Lancet, 2000, 356, 2119.

  32. Jones S.P., et al., Int. J. Obes., 1995, 19 Suppl. 2, 41.

  33. Jones S.P. et al., Int. J. Obes., 1996, 20 Suppl.4, Abst 20-251-FP3.

  34. Kadioglu M. et al., Birth Defects Res. A Clin. Mol. Teratol., 2004, 70, 545.

  35. Kim K.A. et al., Clin. Pharmacol. Ther., 2009, 86 (5), 511.

  36. Lee J. et al., J. Psychosom. Res., 2008, 64 (1), 107.

  37. Luque C.A., Rey J.A., Ann. Pharmacother., 1999, 33 (9), 968.

  38. McLaughlin T. et al., Metabolism, 2001, 50 (7), 819.

  39. McMahon F.G. et al., J. Hum. Hypertens, 2002, 16 (1), 5.

  40. Narkiewicz K., Int. J. Obes. Relat. Metab. Disord., 2002, 26 (Suppl. 4), S38.

  41. Nisolo E., Carruba M.O., Obes. Rev., 2000, 1 (2), 127.

  42. Reiser M. et al., Obes. Rev., 2010, 11 (4), 329.

  43. Robert E et al., Reprod. Toxicol., 1995, 9, 57.

  44. Rolls B.J. et al., Obes. Rev., 1998, 6 (1), 1.

  45. Sari R. et al., Clin. Exp. Med., 2009, consultabile on line http://www.ncbi.nlm.nih.gov/pubmed/19937362

  46. Seebeck J. et al., Int. J. Clin. Pharmacol. Ther., 2008, 46 (7), 375.

  47. Serrano-Rios M. et al., Diabet. Med., 2002, 19 (2), 119.

  48. Sood A. et al., Nicotine Tob. Res., 2009, 11 (12), 1479.

  49. Sramek J.J. et al., J. Hum. Hypertens., 2002, 16 (1), 13.

  50. Starling R.D. et al., Obes. Res., 2001, 9 (4), 251.

  51. Tallett A.J. et al., Behav. Brain Res., 2010, 207 (1), 174.

  52. Wadden T.A. et al., Obes. Res., 2000, 8 (6), 431.

  53. Wesnes K.A. et al., Br. J. Clin. Pharmacol., 2000, 49 (2), 110.

  54. Wilfley D.E. et al., Am. J. Psychiatry, 2008, 165 (1), 51.

  55. Wirth A., Krause J., JAMA, 2001, 286 (11), 1331.

  56. Zannad F. et al., Am. Heart J., 2002, 144 (3), 508.